A Class of Selective Antibacterials Derived from a Protein Kinase Inhibitor Pharmacophore.
Miller, J.R., Dunham, S., Mochalkin, I., Banotai, C., Bowman, M., Buist, S., Dunkle, B., Hanna, D., Harwood, H.J., Huband, M.D., Karnovsky, A., Kuhn, M., Limberakis, C., Liu, J.Y., Mehrens, S., Mueller, W.T., Narasimhan, L., Ogden, A., Ohren, J., Prasad, J.V., Shelly, J.A., Skerlos, L., Sulavik, M., Thomas, V.H., Vanderroest, S., Wang, L., Wang, Z., Whitton, A., Zhu, T., Stover, C.K.(2009) Proc Natl Acad Sci U S A 106: 1737
- PubMed: 19164768 
- DOI: 10.1073/pnas.0811275106
- Primary Citation of Related Structures:  
2V58, 2V59, 2V5A - PubMed Abstract: 
As the need for novel antibiotic classes to combat bacterial drug resistance increases, the paucity of leads resulting from target-based antibacterial screening of pharmaceutical compound libraries is of major concern. One explanation for this lack of success is that antibacterial screening efforts have not leveraged the eukaryotic bias resulting from more extensive chemistry efforts targeting eukaryotic gene families such as G protein-coupled receptors and protein kinases ...